dc.contributor.author | World Health Assembly, 17 | |
dc.coverage.spatial | Geneva | EN |
dc.date.accessioned | 2014-10-15T17:23:30Z | |
dc.date.available | 2014-10-15T17:23:30Z | |
dc.date.issued | 1964 | |
dc.identifier.govdoc | A17/P&B/19 | |
dc.identifier.uri | https://iris.who.int/handle/10665/136510 | |
dc.language.iso | en | EN |
dc.publisher | World Health Organization | EN |
dc.subject | Research | EN |
dc.subject | Pharmaceutical products | EN |
dc.subject.mesh | Research | EN |
dc.subject.mesh | Health Services Research | EN |
dc.subject.mesh | World Health Organization | EN |
dc.subject.mesh | Program Development | EN |
dc.subject.mesh | Pharmaceutical Preparations | EN |
dc.subject.mesh | Drug Evaluation | EN |
dc.subject.mesh | Substance-Related Disorders | EN |
dc.title | Draft fourth report of the Committee on Programme and Budget | EN |
dc.type | Governing body documents | EN |
dc.subject.meshqualifier | organization and administration | EN |
dc.subject.meshqualifier | standards | EN |